List of Pharmacyclics patents

Patents where

Current Assignee

Name

Pharmacyclics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9545407 Formulations of a bruton's tyrosine kinase inhibitor	Patent 9545407 was granted and assigned to Pharmacyclics on January, 2017 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	9545407	January 17, 2017
‌ US Patent 7514444 Inhibitors of bruton's tyrosine kinase	Patent 7514444 was granted and assigned to Pharmacyclics on April, 2009 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	7514444	April 7, 2009
‌ US Patent 10125140 Crystalline forms of a bruton's tyrosine kinase inhibitor	Patent 10125140 was granted and assigned to Pharmacyclics on November, 2018 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	10125140	November 13, 2018
‌ US Patent 10213386 Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor	Patent 10213386 was granted and assigned to Pharmacyclics on February, 2019 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	10213386	February 26, 2019
‌ US Patent 8697711 Inhibitors of bruton'S tyrosine kinase	Patent 8697711 was granted and assigned to Pharmacyclics on April, 2014 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	8697711	April 15, 2014
‌ US Patent 10016435 Use of inhibitors of Bruton's tyrosine kinase (Btk)	Patent 10016435 was granted and assigned to Pharmacyclics on July, 2018 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	10016435	July 10, 2018
‌ US Patent 10266540 Crystalline forms of a Bruton's tyrosine kinase inhibitor	Patent 10266540 was granted and assigned to Pharmacyclics on April, 2019 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	10266540	April 23, 2019
‌ US Patent 9296753 Crystalline forms of a Bruton's tyrosine kinase inhibitor	Patent 9296753 was granted and assigned to Pharmacyclics on March, 2016 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	9296753	March 29, 2016
‌ US Patent 10478439 Use of inhibitors of bruton's tyrosine kinase (Btk)	Patent 10478439 was granted and assigned to Pharmacyclics on November, 2019 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	10478439	November 19, 2019
‌ US Patent 8088781 Inhibitors of brutons tyrosine kinase	Patent 8088781 was granted and assigned to Pharmacyclics on January, 2012 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	8088781	January 3, 2012
‌ US Patent 8735403 Inhibitors of Bruton's tyrosine kinase	Patent 8735403 was granted and assigned to Pharmacyclics on May, 2014 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	8735403	May 27, 2014
‌ US Patent 8232280 Inhibitors of bruton'S tyrosine kinase	Patent 8232280 was granted and assigned to Pharmacyclics on July, 2012 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	8232280	July 31, 2012
‌ US Patent 9273051 Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors	Patent 9273051 was granted and assigned to Pharmacyclics on March, 2016 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	9273051	March 1, 2016
‌ US Patent 7960396 Inhibitors of Bruton's tyrosine kinase	Patent 7960396 was granted and assigned to Pharmacyclics on June, 2011 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	7960396	June 14, 2011
‌ US Patent 8008309 Inhibitors of bruton's tyrosine kinase	Patent 8008309 was granted and assigned to Pharmacyclics on August, 2011 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	8008309	August 30, 2011
‌ US Patent 8703780 Inhibitors of Bruton's tyrosine kinase	Patent 8703780 was granted and assigned to Pharmacyclics on April, 2014 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	8703780	April 22, 2014
‌ US Patent 9181257 Inhibitors of Bruton's tyrosine kinase	Patent 9181257 was granted and assigned to Pharmacyclics on November, 2015 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	9181257	November 10, 2015
‌ US Patent 7112671 Non-symmetric tripyrranes in the synthesis of novel macrocycles	Patent 7112671 was granted and assigned to Pharmacyclics on September, 2006 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	7112671	September 26, 2006
‌ US Patent 7820711 Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders	Patent 7820711 was granted and assigned to Pharmacyclics on October, 2010 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	7820711	October 26, 2010
‌ US Patent 7718662 Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase	Patent 7718662 was granted and assigned to Pharmacyclics on May, 2010 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	7718662	May 18, 2010
‌ US Patent 9125889 Use of inhibitors of Bruton's tyrosine kinase (Btk)	Patent 9125889 was granted and assigned to Pharmacyclics on September, 2015 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	9125889	September 8, 2015
‌ US Patent 8999999 Use of inhibitors of Bruton's tyrosine kinase (Btk)	Patent 8999999 was granted and assigned to Pharmacyclics on April, 2015 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	8999999	April 7, 2015
‌ US Patent 8466193 Selective inhibitors of histone deacetylase	Patent 8466193 was granted and assigned to Pharmacyclics on June, 2013 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	8466193	June 18, 2013
‌ US Patent 7579338 Methods and compositions for treating atheroma, tumors and other neoplastic tissues	Patent 7579338 was granted and assigned to Pharmacyclics on August, 2009 by the United States Patent and Trademark Office.		Pharmacyclics	United States Patent and Trademark Office	7579338	August 25, 2009
‌ US Patent 9795604 Methods of treating and preventing graft versus host disease	Patent 9795604 was granted and assigned to Pharmacyclics on October, 2017 by the United States Patent and Trademark Office.	Pharmacyclics	Pharmacyclics	United States Patent and Trademark Office	9795604	October 24, 2017

...

Results per page:

160 results

0 selected

160 results

0 selected